Clinical Trials for Arcellx

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Arcellx

Clinical Trials (5)

NCT06626919
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
PHASE1Recruiting
30 participants
Started: Apr 30, 2025 · Completed: Apr 30, 2028
7 conditions1 sponsor9 locations
NCT06413498
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
PHASE3Recruiting
450 participants
Started: Aug 23, 2024 · Completed: Jul 31, 2031
1 condition2 sponsors102 locations
NCT05457010
Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS
PHASE1Recruiting
24 participants
Started: Nov 28, 2022 · Completed: Nov 17, 2025
2 conditions1 sponsor5 locations
NCT05396885
Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)
PHASE2Active, not recruiting
129 participants
Started: Aug 9, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors18 locations
NCT04155749
Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma
PHASE1Active, not recruiting
40 participants
Started: Dec 23, 2019 · Completed: Jun 30, 2026
1 condition2 sponsors4 locations